ABVC BioPharma, Inc. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABVC BioPharma, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2025-12-31 was 291.70K shares.
- ABVC BioPharma, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2025-09-30 was 1.01M shares.
- ABVC BioPharma, Inc. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2025 was 1.82M shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 3 month | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 12 month |
|---|---|---|
| 2025-12-31 | 291.70K shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | 1.82M shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 1.01M shares 10-Q/A · filed 2026-03-03 |